List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 68 studies with search of: itp
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Retrospective & Prospective Observational Study of Subjects With ITP
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Other: Retrospective Chart Review;   Other: Patient-reported Outcome Questionnaires;   Other: Physician Survey
2 Active, not recruiting Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Eltrombopag oral tablets
3 Not yet recruiting Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone USP Micronized;   Drug: Prednisone
4 Completed Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: IgNextGen 10%
5 Completed AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Placebo;   Biological: AMG 531
6 Completed AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Interventions: Biological: AMG 531;   Drug: Placebo
7 Withdrawn A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: Rituximab
8 Recruiting Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: PG2
9 Recruiting Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
Condition: Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Intervention: Biological: AMG 531
10 Enrolling by invitation Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Biological: AMG 531
11 Recruiting Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic ITP
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: eltrombopag;   Drug: Placebo
12 Active, not recruiting Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With Chronic ITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Blinded (AKR-501 tablets or placebo);   Drug: Open Label (AKR-501 tablets)
13 Completed RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag
14 Active, not recruiting Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Placebo;   Drug: AKR-501 Tablets
15 Recruiting The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone;   Drug: Dexamethasone and Rituximab
16 Completed Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: AMG 531
17 Recruiting EXTEND (Eltrombopag Extended Dosing Study)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag olamine (SB-497115-GR)
18 Recruiting A Prospective, Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated With Immune (Idiopathic) Thrombocytopenia Purpura (ITP)
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim
19 Active, not recruiting Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: AMG 531;   Drug: Placebo
20 Completed Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation
Condition: Immune Thrombocytopenic Purpura
Interventions: Drug: LGD-4665;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services